- Sun Pharma's Q4 net profit rose 26.2% to Rs 2,714 crore year-on-year
- Revenue increased 12.8% to Rs 14,612 crore in the fourth quarter
- EBITDA grew 6.2% to Rs 3,954 crore, with margin at 27.1% versus 28.7% prior
Sun Pharmaceutical Industries Ltd.'s net profit for the fourth quarter of FY26 surged 26.2% year-on-year, according to an exchange filing on Friday.
The Pharma giant posted a bottom-line of Rs 2,714 crore compared to Rs 2,150 crore in the year-ago period. Revenue went up 12.8% to Rs 14,612 crore from Rs 12,959 crore.
Sun Pharma registered exceptional gains worth approximately Rs 1,700 crore in fiscal 2026. This included exceptional items worth Rs 1,307.5 crore and exceptional tax credit of Rs 385.4 crore for the year ended March 31, 2026.
Follow live earnings updates here.
On the operational front, the Pharma company's earnings before interest, taxes, depreciation and amortisation grew 6.2% year-on-year to Rs 3,954 crore, matching estimates of Rs 3,946 crore. However, the EBITDA margin contracted to 27.1% from 28.7% in the previous year's quarter, but was in-line with estimates of 27.2%.
The company's bottom line was also supported by a higher foreign exchange gain, which climbed to Rs 427 crore against a gain of Rs 291 crore in the same period last year.
The drugmaker has annnounced a final dividend of Rs 5 per share per equity share of Rs 1, subject to shareholder approval.
Sun Pharma Q4 Highlights (Cons, YoY)
Net Profit Up 26.2% At Rs. 2,714 crore Vs Rs. 2,150 crore
- Revenue Up 12.8% At Rs. 14,612 crore Vs Rs. 12,959 crore
- Ebitda Up 6.2% At Rs. 3,954 crore Vs Rs. 3,724 crore
- Ebitda Margin At 27.1% Vs 28.7%
ALSO READ: Bumper Dividend Alert: 3M India Declares Rs 506/Share Payout; Check Record Date
Analysts' Consensus Estimates
Net Profit At Rs. 2,714 crore Vs Estimate of Rs. 2,762 crore
- Revenue At Rs. 14,611.8 crore Vs Estimate of Rs. 14,492 crore
- Ebitda At Rs. 3,954 crore Vs Estimate of Rs. 3,946 crore
- Ebitda Margin At 27% Vs Estimate of 27.2%
Sun Pharma Share Price
The stock fell after the earnings announcement, reaching an intraday low of Rs 1833.10 apiece, down over 3% on the NSE. It pared some losses to trade 2.6% lower at Rs 1,843.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.